Showing 9321-9330 of 18069 results for "".
- Genetic Influences and Treatment Response in Myopiahttps://reachmd.com/news/genetic-influences-and-treatment-response-in-myopia/2475625/Orthokeratology lenses have become an increasingly popular strategy to slow myopic progression, yet substantial interindividual variability in their effectiveness remains. A recent study
- Emerging Roles of AI in Cardiology: Diagnostic Innovations and Financial Shiftshttps://reachmd.com/news/emerging-roles-of-ai-in-cardiology-diagnostic-innovations-and-financial-shifts/2475610/Emerging Roles of AI in Cardiology: Diagnostic Innovations and Financial Shifts Recent advancements in AI-enhanced echocardiography have significantly improved early detection of cardiac amyloidosis, achieving 85% sens
- Monoclonal Antibodies and Their Impact on Lupus Nephritis: A Look into Obinutuzumabhttps://reachmd.com/news/monoclonal-antibodies-and-their-impact-on-lupus-nephritis-a-look-into-obinutuzumab/2475603/Monoclonal antibodies are redefining the treatment landscape in autoimmune kidney diseases, and obinutuzumab's impact on renal outcomes in lupus nephritis signals a pivotal shift in nephrology trials. Lupus nephritis remains a challeng
- Upcoming Skin Cancer Champions Webinar Addresses Impact of AIhttps://reachmd.com/news/Upcoming-Skin-Cancer-Champions-Webinar-Addresses-Impact-AI/2475627/Veronica Rotemberg, MD, PhD, will host a free webinar on the future of non-melanoma skin cancer care August 5 at 1:00 PM ET, Skin Cancer Champions announced. Dr. Rotemberg, Director of Dermatology Imaging Informatics for Memorial Sloan Kettering Cancer Center, will present “The Future of S
- Harnessing AI and Advanced Imaging for Early Cancer Detectionhttps://reachmd.com/news/harnessing-ai-and-advanced-imaging-for-early-cancer-detection/2475578/Recent advancements in cancer detection are being propelled by the integration of artificial intelligence and advanced imaging technologies into diagnostic workflows, providing significant opportunities for early and accurate identification of malignancies. The pursuit of higher diagnostic
- Addressing Gender Disparities in Physician-Patient Interactions for Hidradenitis Suppurativahttps://reachmd.com/news/addressing-gender-disparities-in-physician-patient-interactions-for-hidradenitis-suppurativa/2475585/Addressing gender disparities in physician-patient interactions can enhance treatment outcomes for hidradenitis suppurativa (HS) patients. Dermatologists managing Hidradenitis Suppurativa may sometimes overlook how gender differences s
- Advancing Selective Mutism Diagnosis and Intervention in Early Childhoodhttps://reachmd.com/news/advancing-selective-mutism-diagnosis-and-intervention-in-early-childhood/2475592/Selective mutism typically has an onset between ages three and six, with diagnosis often occurring after school entry, from ages five to eight, as its presentation overlaps with typical shyness and other anxiety disorders. Selective mu
- Understanding RNA Networks in Colorectal Cancer: Implications for Precision Immunotherapyhttps://reachmd.com/news/understanding-rna-networks-in-colorectal-cancer-implications-for-precision-immunotherapy/2475591/The growing understanding of RNA networks, especially long non-coding RNAs (lncRNAs), in the progression of colorectal cancer and their role in immune interactions, has revealed possible molecular weaknesses that could guide the development o
- Increasing Skin-to-Skin Contact Through Targeted Training: Transforming Neonatal Carehttps://reachmd.com/news/increasing-skin-to-skin-contact-through-targeted-training-transforming-neonatal-care/2475587/Clinicians learning that targeted skin-to-skin contact training can significantly increase participation within 48 hours post-birth indicates a significant improvement in neonatal care practices. Despite evidence from systematic review
- Sinclair North America Introduces Inaugural Advisory Boardhttps://reachmd.com/news/sinclair-north-america-introduces-inaugural-advisory-board/2475577/Sinclair North America announced its inaugural Advisory Board, consisting of 16 plastic surgeons, dermatologists, aesthetic practitioners, and aestheticians. The board will advance Sinclair North America’s mission of delivering a timeless and trending portfolio of clinically-validated prod